A Study of LY3375880 in Adults With Moderate-to-Severe Atopic Dermatitis
Clinical trial NCT03831191 · TERMINATED
Trial details
- NCT number
- NCT03831191
- Sponsor
- Eli Lilly and Company
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-12
- Primary completion
- 2020-02-27
- Enrollment
- 136
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.